DocSym
β
Searchsearch
Search
(G37.8) Other specified demyelinating diseases of central nervous system
More details coming soon
549 735 in individuals diagnosis other specified demyelinating diseases of central nervous system confirmed
10 580 deaths with diagnosis other specified demyelinating diseases of central nervous system
2% mortality rate associated with the disease other specified demyelinating diseases of central nervous system
Diagnosis other specified demyelinating diseases of central nervous system is diagnosed Women are 28.32% more likely than Men
197 036
Men receive the diagnosis other specified demyelinating diseases of central nervous system
5 942 (3.0 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
352 699
Women receive the diagnosis other specified demyelinating diseases of central nervous system
4 638 (1.3 %)Died from this diagnosis.
Risk Group for the Disease other specified demyelinating diseases of central nervous system - Men aged 30-34 and Women aged 35-39
In Men diagnosis is most often set at age 0-84
Less common in men the disease occurs at Age 85-95+Less common in women the disease occurs at Age 90-95+
In Women diagnosis is most often set at age 0-89
Disease Features other specified demyelinating diseases of central nervous system
Absence or low individual and public risk
Other specified demyelinating diseases of central nervous system - what does this mean
Other specified demyelinating diseases of the central nervous system occur when the myelin sheath that covers and protects the nerve cells in the brain and spinal cord is damaged or destroyed. this can lead to impaired nerve conduction, inflammation, and damage to the nerve cells, resulting in a variety of neurological symptoms.
What happens during the disease - other specified demyelinating diseases of central nervous system
Other specified demyelinating diseases of the central nervous system are a group of disorders caused by damage to the myelin sheath, the protective covering of nerve fibers. this damage disrupts the transmission of signals within the central nervous system, leading to a variety of symptoms including impaired motor and sensory functions, weakness, fatigue, and vision problems. the exact cause of these diseases is not known, but they are thought to be linked to autoimmune disorders, viral infections, and genetic factors. treatment typically involves medication, physical and occupational therapy, and lifestyle modifications.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Medical history and physical examination
- MRI of the brain and/or spinal cord
- Lumbar puncture (spinal tap) to measure the pressure within the spinal canal and to collect cerebrospinal fluid (CSF) for analysis
- Analysis of CSF for levels of immunoglobulins, white blood cells, and other substances
- Evoked potentials (electrical tests of the nervous system)
- Blood tests to look for signs of inflammation and to rule out other causes of neurological symptoms
Treatment and Medical Assistance
Main goal of treatment: To reduce the severity of symptoms and improve quality of life.
- Medication therapy
- Physical therapy
- Occupational therapy
- Speech therapy
- Psychotherapy
- Cognitive-behavioral therapy
- Vocational rehabilitation
- Nutritional counseling
- Pain management
- Vitamin supplementation
- Exercise
- Relaxation techniques
- Stress management
16 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Other specified demyelinating diseases of central nervous system - Prevention
The best way to prevent other specified demyelinating diseases of the central nervous system is to practice good hygiene, get regular physical activity, eat a healthy diet, and get enough sleep. additionally, avoiding smoking and excessive alcohol consumption can help reduce the risk of developing these diseases.